Literature DB >> 11922559

Generational differences in the age at diagnosis with Ibd: genetic anticipation, bias, or temporal effects.

E M Faybush1, J F Blanchard, P Rawsthorne, C N Bernstein.   

Abstract

OBJECTIVE: Previous cross-sectional research has demonstrated generational differences in age at diagnosis (AAD) in inflammatory bowel disease (IBD). This observation has at times been ascribed to genetic anticipation, but could also be due to biases related to case ascertainment or follow-up or to temporal changes in IBD epidemiology. We aimed to explore this issue using a population-based database.
METHODS: In 1995 we used the comprehensive administrative databases in the province of Manitoba, Canada to establish a population-based IBD Research Registry that includes clinical and demographic information for persons. We contacted those subjects within our Research Registry who reported having any family members with IBD and their family members for verification of diagnosis and AAD. Differences in AAD between familial pairs were calculated. In addition, to assess whether duration of follow-up accounted for generational differences in AAD, we computed the mean AAD for subjects with and without family histories of IBD based on age at the time of interview (i.e., < 45 and > or = 45 yr of age).
RESULTS: Of the 2445 persons with IBD in the Research Registry, 548 reported positive family histories, and 315 of these (58%) were reached by telephone. There were 169 Crohn's disease and 146 ulcerative colitis subjects with positive family histories. The mean AADs for the parents, aunts/uncles, and grandparents were significantly greater than the mean AADs for the children, nieces/nephews, and grandchildren, respectively. There was a doubling of the mean AAD when comparing the grandparent/grandchild cases with the parent/child or aunt/uncle-niece/nephew cases. No statistically significant difference in anticipation was observed, whether or not the older generation was male or female or had Crohn's disease or ulcerative colitis. The AAD was substantially greater for those interviewed at > or = 45 yr of age for subjects with and without family histories. However, there was no substantial difference in mean AAD between familial and nonfamilial subjects.
CONCLUSION: The present study has demonstrated that there is a tendency for children to be younger than their parents at the time of diagnosis of familial IBD, and that this difference in mean AAD is almost doubled for grandparent/grandchild pairs. However, we conclude that these differences are most likely due to a bias based on length of follow-up or recent multigenerational temporal changes in the risk of IBD, or both.

Entities:  

Mesh:

Year:  2002        PMID: 11922559     DOI: 10.1111/j.1572-0241.2002.05542.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  Family and twin studies in inflammatory bowel disease.

Authors:  Leena Halme; Paulina Paavola-Sakki; Ulla Turunen; Maarit Lappalainen; Martti Farkkila; Kimmo Kontula
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 3.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

4.  Poor catch-up growth after proctocolectomy in pediatric patients with ulcerative colitis receiving prolonged steroid therapy.

Authors:  Keiichi Uchida; Toshimitsu Araki; Mikihiro Inoue; Kohei Otake; Shigeyuki Yoshiyama; Yuhki Koike; Kohei Matsushita; Yoshiki Okita; Chikao Miki; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2010-02-24       Impact factor: 1.827

5.  Anticipation in familial pancreatic cancer.

Authors:  C D McFaul; W Greenhalf; J Earl; N Howes; J P Neoptolemos; R Kress; M Sina-Frey; H Rieder; S Hahn; D K Bartsch
Journal:  Gut       Date:  2005-06-21       Impact factor: 23.059

6.  Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.

Authors:  Frederik Trier Moller; Vibeke Andersen; Jan Wohlfahrt; Tine Jess
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

Review 7.  Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Authors:  Maria Teresa Arias-Loste; Beatriz Castro; Montserrat Rivero; Javier Crespo
Journal:  Ann Gastroenterol       Date:  2012

8.  Electroacupuncture intervention of visceral hypersensitivity is involved in PAR-2-activation and CGRP-release in the spinal cord.

Authors:  Manoj K Shah; Yi Ding; Juan Wan; Habibullah Janyaro; Adnan Hassan Tahir; Vitaly Vodyanoy; Ming-Xing Ding
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

9.  A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

Authors:  Elena R Schiff; Matthew Frampton; Francesca Semplici; Stuart L Bloom; Sara A McCartney; Roser Vega; Laurence B Lovat; Eleanor Wood; Ailsa L Hart; Daniel Crespi; Mark A Furman; Steven Mann; Charles D Murray; Anthony W Segal; Adam P Levine
Journal:  Dig Dis Sci       Date:  2018-09-03       Impact factor: 3.199

Review 10.  Familial and ethnic risk in inflammatory bowel disease.

Authors:  Maria Pia Costa Santos; Catarina Gomes; Joana Torres
Journal:  Ann Gastroenterol       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.